Skip to content

Comparison of Phenylephrine and Ephedrine in the treatment of hypotension

Comparison of Phenylephrine and Ephedrine in the treatment of hypotension after spinal anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015070920588N3
Enrollment
110
Registered
2015-11-12
Start date
2015-02-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypotension. Hypotension due to drugs

Interventions

Intervention 1: Intervention group-1 :Will receive 50µg Phenylephrine(group P) intravenousely after observation of hypotension episode(grater than %20 of baseline blood pressure) and in non responsive
Treatment - Drugs
Intervention group-1 :Will receive 50µg Phenylephrine(group P) intravenousely after observation of hypotension episode(grater than %20 of baseline blood pressure) and in non responsive cases ephedrine
Intervention group-2 :Will receive 5mg Ephedrine(group E) intravenousely after observation of hypotension episode(grater than %20 of baseline blood pressure) and in non responsive cases ephedrine will

Sponsors

Vce chancellor for research of Isfahan University of Medical Scienses
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 65 Years

Inclusion criteria

Inclusion criteria: inclusion criteria: 110 patient with ASA physical status class I-II aged 40-65 years who are candidates of lower extremity orthopedic surgery. Exclusion criteria:Any hypersensitivity reaction to vasopressore or local anesthetic drugs, systemic diseases like cardiovascular, liver, or renal diseases and pregnancy.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Systolic blood pressure. Timepoint: 2, 4, 6, 8, 10, 14, 20 and 30 minutes after arrival of the patient to the recovery room. Method of measurement: Noninvasive Blood pressure monitoring system.;Diastolic blood pressure. Timepoint: 2, 4, 6, 8, 10, 14, 20 and 30 minutes after arrival of the patient to the recovery room. Method of measurement: Noninvasive Blood pressure monitoring system.;Mean arterial blood pressure. Timepoint: 2, 4, 6, 8, 10, 14, 20 and 30 minutes after arrival of the patient to the recovery room. Method of measurement: Noninvasive Blood pressure monitoring system.

Secondary

MeasureTime frame
Heart rate. Timepoint: 2 ?4 ? 6 ? 8 ? 10 ? 14 ? 20 and 30 minutes after arrival of the patient to the recovery room. Method of measurement: pulse oxymetery.;Arterial blood oxygen saturation. Timepoint: 2 ?4 ? 6 ? 8 ? 10 ? 14 ? 20 and 30 minutes after arrival of the patient to the recovery room. Method of measurement: pulse oxymetery.;Drug and non drug related complications. Timepoint: Any time during the study. Method of measurement: clinical evaluation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDarioush Moradi

Isfahan University of Medical Sciences

dmoradi@med.mui.ac.irdrdmoradi@gmail.com+98 31 3362 5555

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026